# Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)

> **NCT05423327** · NA · TERMINATED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 5311 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis (NASH)

## Interventions

- **PROCEDURE:** No Intervention

## Key facts

- **NCT ID:** NCT05423327
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-09
- **Primary completion:** 2022-10-27
- **Final completion:** 2022-10-27
- **Target enrollment:** 5311 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2023-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05423327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05423327, "Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05423327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*